The human papillomavirus (HPV) vaccination programme aims to prevent cervical cancer. Globally around 13.1/100,000 women are diagnosed with cervical cancer each year.2 Typically, vaccination is offered to girls aged 9–13 years before sexual debut and naı¨ve to HPV infection. Box 1 gives an overview of licensing and indications in Europe and the US.
Autoimmunity derives from an immune response directed against proteins/structures normally presented within the body of the host. In general, infections precede the onset of autoimmune diseases and, since the 80s, the sharing of sequences/structures between microbial agents and humans has been proposed as the cross-reactive molecular basis for infection-induced autoimmune diseases.
Human papillomavirus (HPV) infection is a well-known sexually transmitted disease. A review of 70 countries worldwide showed an age-stratified HPV prevalence ranging from
Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry